Glassman Wealth Services’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
EC
TCM
BC
GPP
FLAM
FLSM
Glassman Wealth Services's ANAB Position: Q1 2024 in Review
Glassman Wealth Services sold out of AnaptysBio (ANAB) in Q1 2024, closing a stake of 134 shares — an estimated $2.87K sold.
Glassman Wealth Services first reported a position in ANAB in Q3 2020 and held it in 14 quarters. The position peaked at $2.87K in Q4 2023. 133 funds tracked by Wall St. Rank hold ANAB as of Q1 2024.
- Glassman Wealth Services reported no remaining AnaptysBio position as of Q1 2024 after selling out during the quarter.
- Glassman Wealth Services sold 134 AnaptysBio shares in Q1 2024, an estimated $2.87K.
- Glassman Wealth Services first reported a position in AnaptysBio in Q3 2020 and held it in 14 quarters.
- Glassman Wealth Services's AnaptysBio position peaked at $2.87K in Q4 2023.
- 133 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2024.
Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.